Drug Rescue
Innovation Worth Watching: How Ignota Labs Leverages AI to Rescue Promising but Failing Drugs
David Alvaro, Ph.D.
Pharma's Almanac
PAO-08-25-NI-06Aug 06, 2025
CMC
The Biopharma Industry is Well Prepared for an Overhaul of the Lead-to-Clinic CMC Process for Antibodies
Jesse McCool, Ph.D.; David Schmidt, M.B.A., M.Sc.; Oren Beske, Ph.D.; Stephen Monks, Ph.D.
Wheeler Bio
PAO-07-23-CL-05Jul 26, 2023
Preclinical Data
Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data
Mark Mintz; Kristen M. Eisenhauer
Charles River Laboratories
PAO-05-23-CL-03May 05, 2023
Cloud-Based Platform
Charles River Launches Apollo™, an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data
Charles River Laboratories
PR-M03-23-03Mar 14, 2023
Analytical Services
Expecting More for Drug Discovery and Development
Inotiv
PAO-03-22-R250-05Mar 07, 2022
Tissue Models
Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity
Ron Laethem, Ph.D.
Altis Biosystems
PAO-02-21-CL-04Feb 18, 2021
Toxicology
SCYNEXIS Reports Completion of Chronic Nonclinical Toxicology Studies Supporting Long-Term Administration of Ibrexafungerp
SCYNEXIS
PR-M06-19-NI-002Jun 04, 2019
FDA
FDA Purchases Bundle of ADMET Predictor® Licenses
Simulations Plus, Inc.
PR-M05-19-NI-012May 03, 2019
Pharmacokinetic Study
Galmed Reports Positive Results From Pharmacokinetic Split Dose Study of Aramchol
Galmed Pharmaceuticals Ltd.
PR-M03-19-NI-037Mar 13, 2019
Acquisition
Frontage Acquires Concord Biosciences, Adding Preclinical, Agrochemical and Toxicology Services to the Existing Product Development Portfolio
Frontage
PR-M04-18-NI-34Apr 11, 2018
Acquistion
BioIVT Acquires Ascendance Biotechnology, Expanding its Drug Safety Testing and Toxicology Portfolios
BioIVT
PR-M03-18-NI-102-4489Mar 28, 2018